Otros idiomas Vicore Pharma Holding AB

Acciones

VICO

SE0007577895

Mercado cerrado - Nasdaq Stockholm Otros sitios de cotización 17:29:39 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
17,3 ^SEK	+3,72 %		+6,00 %	+22,00 %

04/04	Vicore Pharma Holding AB (Publ) anuncia que Maarten Kraan, como miembro del consejo ha declinado la reelección	CI
19/03	Vicore anuncia la designación de dispositivo innovador por la FDA para AlmeeTM, una terapia digital para pacientes con fibrosis pulmonar	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Vicore to Present at Upcoming April 2024 Investor Conferences	15/04
Vicore to Present at Upcoming Investor Conferences	15/04
Vicore to Present at Upcoming Investor Conferences	12/04
Vicore Pharma Holding AB Announces Maarten Kraan, as Board Member Declined Re-Election	04/04
Notice of annual general meeting of Vicore Pharma Holding AB (publ)	04/04
Vicore Announces Presentations at the 2024 American Thoracic Society International Conference	28/03
Vicore publishes the Annual Report for 2023	27/03
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	19/03
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	19/03
Year-end report 2023	28/02
Vicore Pharma Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Vicore Pharma Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Vicore to Present at Upcoming Investor Conferences	27/02
Vicore Pharma Signs Licensing Deal for Idiopathic Pulmonary Fibrosis Drug Candidate	09/02
Vicore and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize C21 in Japan	09/02
Vicore to Present at Upcoming Investor Conferences	31/01
Alex Therapeutics and Vicore Pharma Announces Positive Results of the COMPANION Study	04/01
Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Therapy for Anxiety	04/01
Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis	04/01
Vicore Pharma Holding AB Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates	02/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Vicore Pharma Holding AB

Acciones

VICO

SE0007577895

Otros idiomas

Filtros